Avet Announces the Launch of Acyclovir Tablets

Avet Pharmaceuticals Inc. announced the immediate availability of Acyclovir Tablets in 400mg and 800mg strengths. This product is the AB rated generic equivalent to the brand Zovirax® and adds to Avet’s robust portfolio of generic oral solid products. According to IMS data for the twelve-months ended July 2013, the U.S. market for Acyclovir Tablets approximated $78 million.

Download Press Release